The HCPLive Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.
December 9th 2024
In this month's episode of Lungcast, Jacob Sands, MD, discusses the American Lung Association’s recently newly-released 2024 State of Lung Cancer report.
Are Environmental and Educational Interventions for Asthma Cost Effective?
While multi-faceted approaches have been shown to be cost-effective, realistically they can be costly and impractical to implement. But environmental and educational interventions hold some promise.
Vertex Initiates Second Phase 3 of Triple Combination for Cystic Fibrosis
March 1st 2018One week after Vertex Pharmaceuticals Incorporated initiated its first Phase 3 study of VX-659, tezacaftor and ivacaftor regimen for people with cystic fibrosis, the company has announced it is initiating a second.
NIH Awards $2.8 Million Grant to PhaseBio for Potential PAH Therapy
A $2.8 million Fast Track Small Business Innovation Research (SBIR) grant has been awarded to PhaseBio Pharmaceuticals from the National Institutes of Health (NIH) to support the clinical development of PB1046 in treating patients with pulmonary arterial hypertension (PAH).